CFO Edward J Dulac III sold $1.2M of Fate Therapeutics, Inc.

Sold$1,216,834

$62.53Price

19,460Shares

−27%Stake

What FATE did after the filing

Prices for FATE after this filing aren't in yet.

Traded Tue, Sep 28. Filed Thu, Sep 30, 12:14 PM ET, during the session. Not investment advice.